Switch to:
GuruFocus has detected 4 Warning Signs with Abbott Laboratories $ABT.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
Abbott Laboratories (NYSE:ABT)
Accounts Payable & Accrued Expense
$6,436 Mil (As of Mar. 2017)

Abbott Laboratories's quarterly accounts payable & accrued expense declined from Sep. 2016 ($5,189 Mil) to Dec. 2016 ($5,090 Mil) but then increased from Dec. 2016 ($5,090 Mil) to Mar. 2017 ($6,436 Mil).

Abbott Laboratories's annual accounts payable & accrued expense declined from Dec. 2014 ($7,203 Mil) to Dec. 2015 ($5,683 Mil) and declined from Dec. 2015 ($5,683 Mil) to Dec. 2016 ($5,090 Mil).


Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Abbott Laboratories Annual Data

Accounts Payable & Accrued Expense 4,9337,9447,82410,86812,10510,8895,9487,2035,6835,090

Abbott Laboratories Quarterly Data

Accounts Payable & Accrued Expense 7,2035,9335,9945,9975,6835,4205,4165,1895,0906,436
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)